THE AMERICA ONE NEWS
Jun 3, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic
Fox Business
Fox Business
28 Apr 2025


President Donald Trump is marking the first 100 days of his second term, highlighting some of the investments companies will make within the United States.
 
Trump promised in December to cut red tape for any company willing to invest $1 billion or more in the U.S.
 
"Any person or company investing ONE BILLION DOLLARS, OR MORE, in the United States of America, will receive fully expedited approvals and permits, including, but in no way limited to, all Environmental approvals," Trump wrote on his social media platform, Truth Social. "GET READY TO ROCK!!!"




 
The following companies, and others, have made such commitments since Trump returned to office in January:

In February, the tech giant announced it would spend more than $500 billion in the U.S. over the next four years. The investments include a new plant in Texas, an educational manufacturing academy and investments in AI and silicon engineering.

Tim Cook/Apple logo split

Tim Cook said he was "bullish" on America's innovative potential in a statement about Apple's investment. (iStock / Getty Images)

"We are bullish on the future of American innovation, and we’re proud to build on our long-standing U.S. investments with this $500 billion commitment to our country’s future," said Apple CEO Tim Cook. "From doubling our Advanced Manufacturing Fund to building advanced technology in Texas, we’re thrilled to expand our support for American manufacturing."

The semiconductor company, which had a market capitalization of $179 billion in April 2020, now boasts a market cap of more than $2.6 trillion, thanks primarily to the explosive growth of AI technology. On April 14, the company announced that it will spend $500 billion on infrastructure, including a manufacturing facility that will build AI supercomputers in the U.S. for the first time.

Nvidia CEO Jensen Huang holds chip

Jensen Huang, co-founder and chief executive officer of Nvidia Corp., holds up the company's AI accelerator chips for data centers. (Akio Kon/Bloomberg via Getty Images / Getty Images)

"The engines of the world’s AI infrastructure are being built in the United States for the first time," said Nvidia CEO Jensen Huang. "Adding American manufacturing helps us better meet the incredible and growing demand for AI chips and supercomputers, strengthens our supply chain, and boosts our resiliency."

The South Korean-based automaker announced in March a $21 billion investment in the U.S. between 2025 and 2028. It includes:

Hyundai store in Pakistan

Hyundai said its investment is expected to create more than 100,000 direct and indirect job opportunities.  (REUTERS/Akhtar Soomro / Reuters Photos)

According to the company, "investment is expected to create more than 100,000 direct and indirect job opportunities by 2028, including 14,000 direct full-time jobs."

When announcing the opening of a new 225,000-square-foot manufacturing facility in Durham, North Carolina, the pharmaceutical manufacturer also said it would invest an additional $8 billion by 2028.

Merck Exterior sign

Merck said it plans to invest an additional $8 billion by 2028. (Photographer: Christopher Occhicone/Bloomberg via Getty Images / Getty Images)

"Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the U.S.," said Sanat Chattopadhyay, executive vice president and president, Merck Manufacturing Division. "The cutting-edge technologies employed here empower our workforce and underscore our leadership in innovation to support patients everywhere."
 
Other companies committed to investing $1 billion or more include Taiwan Semiconductor Manufacturing Company (TSMC), Johnson & Johnson, Eli Lilly, Novartis, Stellantis and Chobani.